 | Metabolic dysfunction–associated steatotic liver disease (MASLD) is the name adopted in 2023 for the condition previously known as non-alcoholic fatty... 129 KB (14,442 words) - 05:01, 6 May 2024 |
 | cirrhosis, liver cancer, and esophageal varices. The main subtypes of fatty liver disease are metabolic dysfunction–associated steatotic liver disease (MASLD... 38 KB (3,896 words) - 23:48, 18 April 2024 |
 | high-density lipoprotein (HDL). Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. In the U.S.... 59 KB (6,651 words) - 19:12, 8 May 2024 |
 | Steatohepatitis (category Diseases of liver) constitute fatty liver changes. There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (previously... 6 KB (467 words) - 12:02, 13 March 2024 |
 | Semaglutide (category Experimental drugs developed for non-alcoholic fatty liver disease) lowering liver enzymes (transaminitis) and improving certain radiologically observed features of metabolic dysfunction–associated steatotic liver disease. French... 66 KB (5,371 words) - 04:16, 8 May 2024 |
 | SUCNR1 (section Liver diseases) Sanyal AJ (September 2023). "Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient... 73 KB (9,204 words) - 07:47, 29 April 2024 |